Rouan Sarah Kathryn

Rouan Sarah Kathryn is listed in filings as Director at Viking Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 5, 2026, including purchase activity and sale activity. Recent filings connect the profile to Viking Therapeutics, Inc. (VKTX). The current snapshot covers public activity from Oct 25, 2024 to Jan 5, 2026. Reported amounts are shown as $722.6K to $773.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.